Back

Safety and efficacy of 3-month dual antiplatelet therapy after drug-eluting stents: a network bayesan meta-analysis of randomised clinical trials

27 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Interventional cardiology - General aspects Adjunctive Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Giuseppe Ferrante

Humanitas University, Milan (Italy)

11 More presentations in this session

Presentation thumbnail
Doctor S. Burgess (Sydney, AU)
Abstract Slides
Presentation thumbnail
Professor K. Kozuma (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Miss F. Saraiva (Porto, PT)
Abstract
Presentation thumbnail
Doctor S. Mehta (Miami, US)
Abstract Slides
Presentation thumbnail
Doctor N. Corballis (Norwich, GB)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Interventional cardiology - General aspects

The Event

Event poster

ESC Congress 2018

27 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Comparative efficacy and safety of de-escalation, abbreviation, and standard potent P2Y12 inhibitor based DAPT strategies after acute coronary syndrome: a network meta analysis
21 March 2026
thumbnail
Congress Presentation
A shorter duration of dual-antiplatelet therapy following percutaneous coronary intervention by region of study: a meta-analysis of randomized clinical trials
30 August 2025
thumbnail
Congress Presentation
Using bayesian method and network meta-analysis to augment the trial interpretation of RAAS inhibitor effects in patients
21 May 2023
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources